Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,19 USD | -1,65% | +6,14% | -61,86% |
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 17,64 mln. 16,47 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -17 mln. -15,87 mln. | Nettowinst (verlies) 2023 | -10 mln. -9,34 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 13,25 mln. 12,37 mln. | Nettoliquiditeiten 2023 | 3,84 mln. 3,59 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,65
x | K/w-verhouding 2023 |
-1,53
x | Werknemers | 11 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 28,78% |
Recentste transcriptie over Akari Therapeutics, Plc
1 dag | -1,65% | ||
1 week | +6,14% | ||
Lopende maand | -36,19% | ||
1 maand | -34,25% | ||
3 maanden | -55,26% | ||
6 maanden | -66,00% | ||
Lopend jaar | -61,86% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jacques Suzanne
CEO | Chief Executive Officer | 53 | 28-03-22 |
Founder | 79 | 01-09-15 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 19-07-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 01-06-16 |
Founder | 79 | 01-09-15 | |
Director/Board Member | 61 | 05-07-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 1,19 | -1,65% | 7 532 |
23-04-24 | 1,21 | +2,54% | 4 872 |
22-04-24 | 1,18 | +1,18% | 13 919 |
19-04-24 | 1,166 | -3,62% | 3 740 |
18-04-24 | 1,21 | +7,92% | 8 776 |
uitgestelde koers Nasdaq, 24 april 2024 om 22:30 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-61,86% | 9,43 mln. | |
-1,51% | 104 mld. | |
+3,22% | 97,42 mld. | |
+1,86% | 22,2 mld. | |
-16,53% | 21,23 mld. | |
-8,49% | 18,33 mld. | |
-42,33% | 16,35 mld. | |
-20,09% | 15,06 mld. | |
+5,47% | 13,98 mld. | |
+28,85% | 11,66 mld. |